{"id":15851,"date":"2024-11-15T20:08:59","date_gmt":"2024-11-15T18:08:59","guid":{"rendered":"https:\/\/www.arnoschrauwers.nl\/weblog\/?p=15851"},"modified":"2024-11-15T20:08:59","modified_gmt":"2024-11-15T18:08:59","slug":"eu-keurt-lecanemab-goed-als-alzheimerremmer","status":"publish","type":"post","link":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/","title":{"rendered":"EU keurt lecanemab goed als Alzheimerremmer"},"content":{"rendered":"<p>Ondanks de <a href=\"https:\/\/synbio.arnoschrauwers.nl\/?s=Lecanemab&amp;submit=Zoeken\">niet al te florissante klinische proeven<\/a> met het middel is <a href=\"https:\/\/nl.wikipedia.org\/wiki\/Lecanemab\">lecanemab<\/a> goedgekeurd voor toelating in de EU <a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/leqembi\">door het Europese medicijnenagentschap<\/a>. Reden is waarschijnlijk dat er nog steeds geen geneesmiddel of -wijze voor de ziekte bestaat.<!--more--><br \/>\nTijdens klinische proeven stierven <a href=\"https:\/\/synbio.arnoschrauwers.nl\/28\/11\/2022\/lecanemab-lijkt-niet-het-aangewezen-medicijn-tweede-dode-bij-alzheimerproeven\/\">ten minste twee proefpersonen<\/a> in een groep van 1800. Ook geneest het <a href=\"https:\/\/nl.wikipedia.org\/wiki\/Immunoglobuline\">antilichaam<\/a> (de ab in de naam), maar lacanemab remt de voortgang van de ziekte alleen wat af. Het middel was vorig jaar al toegelaten in de VS.<\/p>\n<p>Leqembi (merknaam van aanvrager <a href=\"https:\/\/www.eisai.eu\/\">Eisai GmbH<\/a>) is ge\u00efndiceerd voor de behandeling van volwassen pati\u00ebnten met milde cognitieve stoornissen en milde dementie als gevolg van de ziekte van Alzheimer, die niet-drager zijn van apolipoprote\u00efne E \u03b54 (ApoE \u03b54) of heterozygoten zijn met bevestigde amylo\u00efdpathologie, schrijft het EMA.<\/p>\n<p><em>Bron: <a href=\"https:\/\/www.dw.com\/de\/alzheimer-medikament-ema-gibt-gr\u00fcnes-licht-f\u00fcr-lecanemab\/a-66873802?maca=de-rss-de-wissenschaft-4019-xml-mrss\">dw.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Het middel lacanemab, een Alzheimerremmer, is toegelaten door het EMA tot de EU, ondanks vrij beroerde klinische proeven en werkzaamheid. <a href=\"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/\">Lees verder <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,96],"tags":[2564,6892,1178,8703,10247,1531],"class_list":["post-15851","post","type-post","status-publish","format-standard","hentry","category-gezondheid","category-hersens","tag-antilichaam","tag-ema","tag-eu","tag-lecanemab","tag-toelating","tag-ziekte-van-alzheimer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EU keurt lecanemab goed als Alzheimerremmer - Geleerd uitschot %<\/title>\n<meta name=\"description\" content=\"Het middel lacanemab, een Alzheimerremmer, is toegelaten door het EMA tot de EU, ondanks vrij beroerde klinische proeven en werkzaamheid.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU keurt lecanemab goed als Alzheimerremmer - Geleerd uitschot %\" \/>\n<meta property=\"og:description\" content=\"Het middel lacanemab, een Alzheimerremmer, is toegelaten door het EMA tot de EU, ondanks vrij beroerde klinische proeven en werkzaamheid.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/\" \/>\n<meta property=\"og:site_name\" content=\"Geleerd uitschot\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-15T18:08:59+00:00\" \/>\n<meta name=\"author\" content=\"arno s\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"arno s\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/\"},\"author\":{\"name\":\"arno s\",\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/#\\\/schema\\\/person\\\/8c74e34597e3e2a46ff9b2fb8483fde2\"},\"headline\":\"EU keurt lecanemab goed als Alzheimerremmer\",\"datePublished\":\"2024-11-15T18:08:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/\"},\"wordCount\":137,\"commentCount\":0,\"keywords\":[\"antilichaam\",\"EMA\",\"EU\",\"lecanemab\",\"toelating\",\"ziekte van Alzheimer\"],\"articleSection\":[\"gezondheid\",\"hersens\"],\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/\",\"url\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/\",\"name\":\"EU keurt lecanemab goed als Alzheimerremmer - Geleerd uitschot %\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/#website\"},\"datePublished\":\"2024-11-15T18:08:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/#\\\/schema\\\/person\\\/8c74e34597e3e2a46ff9b2fb8483fde2\"},\"description\":\"Het middel lacanemab, een Alzheimerremmer, is toegelaten door het EMA tot de EU, ondanks vrij beroerde klinische proeven en werkzaamheid.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/15\\\/11\\\/2024\\\/eu-keurt-lecanemab-goed-als-alzheimerremmer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU keurt lecanemab goed als Alzheimerremmer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/#website\",\"url\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/\",\"name\":\"Geleerd uitschot\",\"description\":\"Over wetenschap en ander vermaak\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.arnoschrauwers.nl\\\/weblog\\\/#\\\/schema\\\/person\\\/8c74e34597e3e2a46ff9b2fb8483fde2\",\"name\":\"arno s\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bb84bca689a0564d3856b4db510b1c81bd818da9cf10a0ca85a6a84687de5ad3?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bb84bca689a0564d3856b4db510b1c81bd818da9cf10a0ca85a6a84687de5ad3?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bb84bca689a0564d3856b4db510b1c81bd818da9cf10a0ca85a6a84687de5ad3?s=96&d=blank&r=g\",\"caption\":\"arno s\"},\"sameAs\":[\"http:\\\/\\\/www.arnoschrauwers.nl\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU keurt lecanemab goed als Alzheimerremmer - Geleerd uitschot %","description":"Het middel lacanemab, een Alzheimerremmer, is toegelaten door het EMA tot de EU, ondanks vrij beroerde klinische proeven en werkzaamheid.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/","og_locale":"nl_NL","og_type":"article","og_title":"EU keurt lecanemab goed als Alzheimerremmer - Geleerd uitschot %","og_description":"Het middel lacanemab, een Alzheimerremmer, is toegelaten door het EMA tot de EU, ondanks vrij beroerde klinische proeven en werkzaamheid.","og_url":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/","og_site_name":"Geleerd uitschot","article_published_time":"2024-11-15T18:08:59+00:00","author":"arno s","twitter_misc":{"Geschreven door":"arno s","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/#article","isPartOf":{"@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/"},"author":{"name":"arno s","@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/#\/schema\/person\/8c74e34597e3e2a46ff9b2fb8483fde2"},"headline":"EU keurt lecanemab goed als Alzheimerremmer","datePublished":"2024-11-15T18:08:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/"},"wordCount":137,"commentCount":0,"keywords":["antilichaam","EMA","EU","lecanemab","toelating","ziekte van Alzheimer"],"articleSection":["gezondheid","hersens"],"inLanguage":"nl-NL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/","url":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/","name":"EU keurt lecanemab goed als Alzheimerremmer - Geleerd uitschot %","isPartOf":{"@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/#website"},"datePublished":"2024-11-15T18:08:59+00:00","author":{"@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/#\/schema\/person\/8c74e34597e3e2a46ff9b2fb8483fde2"},"description":"Het middel lacanemab, een Alzheimerremmer, is toegelaten door het EMA tot de EU, ondanks vrij beroerde klinische proeven en werkzaamheid.","breadcrumb":{"@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/15\/11\/2024\/eu-keurt-lecanemab-goed-als-alzheimerremmer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arnoschrauwers.nl\/weblog\/"},{"@type":"ListItem","position":2,"name":"EU keurt lecanemab goed als Alzheimerremmer"}]},{"@type":"WebSite","@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/#website","url":"https:\/\/www.arnoschrauwers.nl\/weblog\/","name":"Geleerd uitschot","description":"Over wetenschap en ander vermaak","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arnoschrauwers.nl\/weblog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Person","@id":"https:\/\/www.arnoschrauwers.nl\/weblog\/#\/schema\/person\/8c74e34597e3e2a46ff9b2fb8483fde2","name":"arno s","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/bb84bca689a0564d3856b4db510b1c81bd818da9cf10a0ca85a6a84687de5ad3?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bb84bca689a0564d3856b4db510b1c81bd818da9cf10a0ca85a6a84687de5ad3?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bb84bca689a0564d3856b4db510b1c81bd818da9cf10a0ca85a6a84687de5ad3?s=96&d=blank&r=g","caption":"arno s"},"sameAs":["http:\/\/www.arnoschrauwers.nl"]}]}},"_links":{"self":[{"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/posts\/15851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/comments?post=15851"}],"version-history":[{"count":1,"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/posts\/15851\/revisions"}],"predecessor-version":[{"id":15852,"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/posts\/15851\/revisions\/15852"}],"wp:attachment":[{"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/media?parent=15851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/categories?post=15851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arnoschrauwers.nl\/weblog\/wp-json\/wp\/v2\/tags?post=15851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}